Evidence map›Paper›PMID 38166466›Full record

ArticleToxicology and industrial health2024

Risk assessment-based verification of the CertiPUR

Patrick de Kort, Elke Jensen, Mark W Spence, Patrick M Plehiers

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Toxicology and industrial health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Patrick de KortEUROPUR AISBL, Brussels, Belgium.ORCID 0000-0003-0752-1565
Elke JensenThe Dow Chemical Company, Midland, MI, USA.
Mark W SpenceInternational Isocyanate Institute, Inc, Mountain Lakes, NJ, USA.ORCID 0000-0003-1050-3333
Patrick M PlehiersInternational Isocyanate Institute, Inc, Mountain Lakes, NJ, USA.ORCID 0000-0002-4630-5016
International Isocyanate Institute, Inc.Association des Operateurs Postaux Publics Europeens · BEDow Chemical (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Flexible polyurethane foams (PUF) are used in many consumer products. PUF may contain trace levels of aromatic diamine impurities that could represent a potential health risk. The risk associated with sleeping on a PUF mattress was evaluated. Toxicity benchmarks for sensitization and non-cancer endpoints were derived from the respective points-of-departure using standard assessment factors. For the cancer endpoints, toxicity benchmarks were derived from the 25th-percentile values of animal studies. Recently published emission and migration data allowed to link exposure with the CertiPUR

Indexed as

DiaminesPolyurethanesAnimalsRisk AssessmentTolueneDiaminespolyurethane foamPolyurethanesToluenearomatic diaminesCertiPURemissionmethylene dianiline (MDA)migrationPolyurethane (PU) foamrisk assessmenttoluene diamine (TDA)

Identifiers

PMID38166466
PMCPMC10851636
OpenAlexW4390541081

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.